Principal Financial Group
IDYA icon

Principal Financial Group’s IDEAYA Biosciences IDYA Stock Holding History

Principal Financial Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,720
Closed -$245K – 2227
2024
Q3 		$245K Sell
7,720
-4,968
-39% -$188K ﹤0.01% 2068
2024
Q2 		$445K Sell
12,688
-2,587
-17% -$102K ﹤0.01% 1983
2024
Q1 		$670K Buy
15,275
+648
+4% +$27.9K ﹤0.01% 1929
2023
Q4 		$520K Buy
14,627
+212
+1% +$6.33K ﹤0.01% 1957
2023
Q3 		$389K Buy
14,415
+676
+5% +$17.1K ﹤0.01% 2002
2023
Q2 		$323K Buy
13,739
+1,572
+13% +$32.3K ﹤0.01% 2059
2023
Q1 		$167K Buy
12,167
+1,729
+17% +$28.8K ﹤0.01% 2213
2022
Q4 		$190K Buy
+10,438
New +$176K ﹤0.01% 2207
2022
Q2 		– Sell
-18,997
Closed -$213K – 2573
2022
Q1 		$213K Sell
18,997
-7,601
-29% -$112K ﹤0.01% 2322
2021
Q4 		$629K Buy
+26,598
New +$618K ﹤0.01% 2075

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Principal Financial Group's IDYA Position: Q4 2024 in Review

Principal Financial Group sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 7,720 shares — an estimated $245K sold.

Principal Financial Group first reported a position in IDYA in Q4 2021 and held it in 10 quarters. The position peaked at $670K in Q1 2024. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • Principal Financial Group reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Principal Financial Group sold 7,720 IDEAYA Biosciences shares in Q4 2024, an estimated $245K.
  • Principal Financial Group first reported a position in IDEAYA Biosciences in Q4 2021 and held it in 10 quarters.
  • Principal Financial Group's IDEAYA Biosciences position peaked at $670K in Q1 2024.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Principal Financial Group's 13F filing for Q4 2024, filed 31 Jan 2025.